High-Throughput (Sub-2.5 Second) Direct Injection Analysis by Mass Spectrometry

Significance of the Topic

Mass spectrometry (MS) is a cornerstone technique in early drug discovery and biochemical screening due to its high sensitivity and direct detection capabilities. As compound libraries expand into tens of thousands of samples, traditional liquid chromatography (LC) and solid-phase extraction MS (SPE/MS) workflows can become rate-limiting in high-throughput environments.

Study Objectives and Overview

This application note presents a modification of an Agilent RapidFire 365 high-throughput MS system to eliminate the SPE desalting step and enable direct injection, achieving sub-2.5-second analysis per sample. The aim is to demonstrate the enhanced throughput, linearity, and reproducibility of the direct injection approach compared to the standard RapidFire configuration.

Methodology and Instrumentation

The workflow modification involved rerouting the flow path between valve positions to bypass the desalting cartridge. Key method parameters were optimized to balance speed, signal quality, and separation:

• Elution flow rate set to 1.25 mL/min
• Elution time of 500 ms
• Throughput testing with 60 injections in approximately two minutes (~2 s/sample)

Used Instrumentation

• Modified Agilent RapidFire 365 system
• Agilent 6470 triple quadrupole LC/MS detector
• Microplate autosampler with aqueous dilution and direct injection capability

Main Results and Discussion

• Throughput: The modified system sustained a cycle time of just over two seconds per sample, enabling analysis of up to 35,000 samples in 24 h.
• Linearity: A 14-point, two-fold dilution series of S-adenosylhomocysteine (SAH) yielded an R2 of 0.9997 over a 0.98–8,000 nM range.
• Reproducibility: Replicate injections (1,920 per concentration) exhibited coefficients of variation between 1–2 % across tested SAH levels.
• Correlation: Direct injection data correlated strongly with standard SPE/MS mode (R2 = 0.9983), confirming quantitative agreement.

Benefits and Practical Applications

The direct injection approach offers several advantages for high-throughput screening:

• Improved sample throughput (3–5× faster than standard SPE workflows)
• Broad and linear quantitation over multiple orders of magnitude
• High reproducibility suitable for large compound libraries
• Flexibility to analyze diverse analyte panels without SPE enrichment biases
• Ability to process samples unsuitable for standard SPE due to matrix complexity

Future Trends and Applications

Direct injection MS platforms are poised to transform high-throughput screening by further streamlining workflows and integrating with automated sample preparation. Future developments may include advanced flow control, real-time data processing with machine learning, and expansion to omics-scale analyses where rapid, label-free quantitation is critical.

Conclusion

By bypassing SPE desalting, the modified RapidFire-MS system achieves sub-2.5-second sample cycles with excellent linearity and reproducibility, matching standard mode accuracy while dramatically increasing throughput. This approach supports efficient large-scale screenings and opens new possibilities for complex sample matrices in drug discovery.